Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 13 Sept 2010 |
| Genmab Announces Results of Ofatumumab Phase II Study in Multiple Sclerosis | 10 Sept 2010 |
| Genmab to Present at Two Investor Conferences in September | 8 Sept 2010 |
| GSK and Genmab Announce Start of Ofatumumab Phase III Combination Study in Non-Hodgkin's Lymphoma | 8 Sept 2010 |
| Interim Report for the 6 months ended June 30, 2010 | 17 Aug 2010 |